Cardiovascular Journal of Africa: Vol 24 No 1 (February 2013) - page 2

A c omp e l l i n g c h o i c e f o r ma n y p a t i e n t s a t mo d e r a t e c v r i s k wh o d o c t o r s
s e e e v e r y d a y – “ d emo n s t r a t e s t h a t t h e r i s k o f h e a r t a t t a c k s c a n
b e mo r e t h a n h a l v e d i n t h e s e p a t i e n t s ”
Our BIG 3
Cipla Medpro (Pty) Ltd. Reg. No. 1995/004182/07, Rosen Heights, Pasita Street, Rosen Park, Bellville, 7530. Tel (021) 943 4200, Fax (021) 914 4699.
E-mail:medicalpa@ciplamedpro.co.zaWebsite: www.cipla.co.za
S3 Reg. No. 41/7.1.3/0671, 72
S3 Reg. No. 39/7.1/0117, 0120
S4 Reg. No. 42/7.5/0552, 0553, 0554, 0555
team
Trus t ed
Ev idence based
Af f ordab l e
Med i c i ne
Atorvastatin
10 mg , 20 mg, 40 mg, 80 mg
Amlodipine Besylate 5 mg / 10 mg
Perindopril Erbumine 4 mg / 8 mg
References
1. Sever PS, Dahlof B, Poulter N, Wedel H, et al, for the ASCOT Investigators. Lancet. 2003;361:1149-58